Inventor
Martin C. Woodle
Inventor
Menlo Park, CA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C12NMicroorganisms or enzymes11%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
Y02ATechnologies for adaptation to climate change6%
Y10TTechnical subjects covered by former us classification4%
C07HSugars2%
C07KPeptides2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
8,691,781'Compositions for treating respiratory viral infections and their use'20147,893,244'Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases'20117,893,243'Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases'20117,786,092'Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases'20107,781,414'Targets for tumor growth inhibition'20107,723,316'Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases'20107,534,878'Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases'20097,160,554'Enhanced circulation effector composition and method'20077,150,882'Enhanced circulation effector composition and method'20066,586,002'Enhanced circulation effector composition and method'20036,326,353'Enhanced circulation effector composition and method'20016,180,134'Enhanced ciruclation effector composition and method'20015,843,473'Method of treatment of infected tissues'19985,631,018'Lipid-polymer conjugates and liposomes'19975,395,619'Lipid-polymer conjugates and liposomes'19955,356,633'Method of treatment of inflamed tissues'19945,225,212'Microreservoir liposome composition and method'19935,213,804'Solid tumor treatment method and composition'19935,013,556'Liposomes with enhanced circulation time'19914,927,637'Liposome extrusion method'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–1995Patents assigned to LIPOSOME TECHNOLOGY INC (6)· patent assignee history
1990–2007Based in Menlo Park, CA, US· patent location history
1997–2001Patents assigned to SEQUUS PHARM INC (4)· patent assignee history
2003–2007Patents assigned to ALZA CORP (3)· patent assignee history
2009–2011Patents assigned to INTRADIGM CORP (6)· patent assignee history
2009–2014Based in Bethesda, MD, US· patent location history
2014Patents assigned to LU PATRICK (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INTRADIGM CORP | 6 | 2009–2011 |
| LIPOSOME TECHNOLOGY INC | 6 | 1990–1995 |
| SEQUUS PHARM INC | 4 | 1997–2001 |
| ALZA CORP | 3 | 2003–2007 |
| LU PATRICK | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Menlo Park, California, US | 13 | 1990–2007 |
| Bethesda, Maryland, US | 7 | 2009–2014 |